NDA 19950, held by Pfizer. Fluconazole.
As of Nov 14, 2026, NDA 19950 (Diflucan In Sodium Chloride 0.9%, Diflucan In Sodium Chloride 0.9% In Plastic Container, Diflucan In Dextrose 5% In Plastic Container), held by Pfizer, was first approved by FDA on Jan 29, 1990, with 46 approved supplements and 0 published complete response letters.
| Nov 23, 1994 | Supplement 16Efficacy (new indication or use) · Standard review | Approved | None posted |
| Dec 30, 1993 | Supplement 4Efficacy (new indication or use) | Approved | None posted |
| Jan 29, 1990 | Original applicationNew dosage form · Standard review | Approved | None posted |
| Diflucan In Sodium Chloride 0.9%200MG/100ML (2MG/ML) · injectable;injection | Fluconazole | DiscontinuedReference drug |
| Diflucan In Sodium Chloride 0.9% In Plastic Container200MG/100ML (2MG/ML) · injectable;injection | Fluconazole | DiscontinuedReference drug |
| Diflucan In Dextrose 5% In Plastic Container200MG/100ML (2MG/ML) · injectable;injection | Fluconazole | DiscontinuedReference drug |
| Diflucan In Sodium Chloride 0.9% In Plastic Container400MG/200ML (2MG/ML) · injectable;injection | Fluconazole | DiscontinuedReference drug |
| Diflucan In Dextrose 5% In Plastic Container400MG/200ML (2MG/ML) · injectable;injection | Fluconazole | DiscontinuedReference drug |
| Diflucan In Sodium Chloride 0.9%400MG/200ML (2MG/ML) · injectable;injection | Fluconazole | DiscontinuedReference drug |
| Feb 12, 2024 | Supplement 71Labeling · Standard review | Approved | |
| Jul 12, 2023 | Supplement 73Labeling · Standard review | Approved | |
| Jan 17, 2023 | Supplement 72Labeling · Standard review | Approved | |
| Mar 9, 2022 | Supplement 70Labeling · Standard review | Approved | |
| Oct 25, 2021 | Supplement 69Labeling · Standard review | Approved | |
| Sep 8, 2020 | Supplement 68Labeling · Standard review | Approved | |
| Nov 7, 2019 | Supplement 67Labeling · Standard review | Approved | |
| Nov 7, 2019 | Supplement 66Labeling · Standard review | Approved | |
| Jun 1, 2015 | Supplement 65Manufacturing | Approved | None posted |
| Jul 28, 2014 | Supplement 63Manufacturing | Approved | None posted |
| Mar 24, 2014 | Supplement 62Labeling · Standard review | Approved | |
| Sep 13, 2013 | Supplement 61Labeling · Standard review | Approved | |
| Nov 16, 2011 | Supplement 59Labeling · Standard review | Approved | |
| Jun 6, 2011 | Supplement 56Labeling | Approved | |
| Apr 26, 2011 | Supplement 57Labeling | Approved | |
| Aug 5, 2010 | Supplement 53Labeling | Approved | |
| Mar 31, 2008 | Supplement 43Labeling · Standard review | Approved | |
| Oct 7, 2004 | Supplement 37Labeling · Standard review | Approved | |
| Oct 7, 2004 | Supplement 33Labeling · Standard review | Approved | |
| Oct 7, 2004 | Supplement 31Labeling · Standard review | Approved | |
| Mar 24, 2004 | Supplement 39Labeling · Standard review | Approved | |
| Aug 7, 2002 | Supplement 34Labeling · Standard review | Approved | None posted |
| Mar 5, 2001 | Supplement 32Manufacturing | Approved | None posted |
| Sep 29, 1999 | Supplement 30Manufacturing | Approved | None posted |
| Sep 29, 1999 | Supplement 29Manufacturing | Approved | None posted |
| Feb 22, 1999 | Supplement 28Labeling · Standard review | Approved | None posted |
| Feb 13, 1998 | Supplement 27Manufacturing | Approved | None posted |
| Aug 5, 1997 | Supplement 26Labeling · Standard review | Approved | None posted |
| Feb 19, 1997 | Supplement 25Labeling · Standard review | Approved | None posted |
| Aug 6, 1996 | Supplement 24Labeling · Standard review | Approved | None posted |
| Jul 23, 1996 | Supplement 22Labeling · Standard review | Approved | None posted |
| Dec 22, 1995 | Supplement 21Manufacturing | Approved | None posted |
| Mar 20, 1995 | Supplement 20Manufacturing | Approved | None posted |
| Mar 9, 1995 | Supplement 19Manufacturing | Approved | None posted |
| Nov 23, 1994 | Supplement 16Efficacy (new indication or use) · Standard review | Approved | None posted |
| Aug 22, 1994 | Supplement 17Manufacturing | Approved | None posted |
| Jul 8, 1994 | Supplement 12Manufacturing | Approved | None posted |
| Jun 30, 1994 | Supplement 18Labeling · Standard review | Approved | None posted |
| Dec 30, 1993 | Supplement 4Efficacy (new indication or use) | Approved | None posted |
| Oct 13, 1993 | Supplement 3Labeling | Approved | None posted |
| Oct 13, 1993 | Supplement 7Labeling | Approved | None posted |
| Oct 13, 1993 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jun 22, 1993 | Supplement 11Manufacturing | Approved | None posted |
| Jun 14, 1993 | Supplement 8Manufacturing | Approved | None posted |
| Feb 10, 1993 | Supplement 9Manufacturing | Approved | None posted |
| Sep 29, 1992 | Supplement 2Manufacturing | Approved | None posted |
| Jan 29, 1990 | Original applicationNew dosage form · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters